Compare Edwards Lifesciences Corporation Common Stock (EW) vs Invesco S&P 500 Low Volatility ETF (SPLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Invesco S&P 500 Low Volatility ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.21 (market cap $48.56B), while Invesco S&P 500 Low Volatility ETF trades at $72.14 (market cap $6.94B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7× Invesco S&P 500 Low Volatility ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Invesco S&P 500 Low Volatility ETF nearer its low. Which is the better fit depends on your goals.
| EW | SPLV | |
|---|---|---|
Market Cap | $48.56B | $6.94B |
Volume | 6,520,488 | 1,663,703 |
Sector | Health | — |
52-Week High | $95.18 | $77.97 |
52-Week Low | $72.65 | $70.30 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 123 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPLV, the Invesco S&P 500 Low Volatility ETF, trades at $72.14 with a 1.29% daily gain, though technical indicators show a bearish trend with moving averages signaling caution. The ETF's sector allocation to Utilities, Real Estate, and Financials has contributed to underperformance relative to the broader S&P 500, with a 5% return versus 17% for the index. Recent dividend distributions of $0.14 per share provide income support amid market volatility.
The outlook remains neutral with valuation concerns at a 19.5x P/E ratio creating headwinds, while geopolitical tensions and sector-specific risks pose challenges. Opportunities exist for investors seeking stability during market uncertainty, though growth potential appears limited compared to broader market ETFs. Key risks include continued sector underperformance and macroeconomic pressures on defensive holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Invesco S&P 500 Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →
